---
figid: PMC8005514__fphar-12-628690-g003
figlink: pmc/articles/PMC8005514/figure/F3/
number: F3
caption: PI3K/AKT pathway and HER2-targeted therapy resistance. High expression of
  the HER2 truncated mutant (p95-HER2), the most common form of HER2 structural change,
  is related to HER2-targeted therapy resistance through activating the PI3K/AKT pathway.
  Trastuzumab treatment increases HER3 expression and leads to PI3K/AKT activation
  along with subsequent resistance to anti-HER2 therapy. Additionally, PI3KCA mutations,
  PTEN loss or both, also contribute to PI3K activation and then promote cell proliferation
  along with resistance to HER2-targeted therapy.
pmcid: PMC8005514
papertitle: Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer.
reftext: Chao Dong, et al. Front Pharmacol. 2021;12:628690.
pmc_ranked_result_index: '7474'
pathway_score: 0.9554588
filename: fphar-12-628690-g003.jpg
figtitle: PI3K/AKT pathway and HER2-targeted therapy resistance
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8005514__fphar-12-628690-g003.html
  '@type': Dataset
  description: PI3K/AKT pathway and HER2-targeted therapy resistance. High expression
    of the HER2 truncated mutant (p95-HER2), the most common form of HER2 structural
    change, is related to HER2-targeted therapy resistance through activating the
    PI3K/AKT pathway. Trastuzumab treatment increases HER3 expression and leads to
    PI3K/AKT activation along with subsequent resistance to anti-HER2 therapy. Additionally,
    PI3KCA mutations, PTEN loss or both, also contribute to PI3K activation and then
    promote cell proliferation along with resistance to HER2-targeted therapy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - ERBB2
  - ERBB3
  - MUC4
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - HRAS
  - KRAS
  - NRAS
  - PLP2
  - AKT2
  - AKT3
  - AKT1
  - PTEN
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - MARK1
  - Lapatinib
  - Afatinib
  - Pelitinib
genes:
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Muc4
  symbol: MUC4
  source: hgnc_symbol
  hgnc_symbol: MUC4
  entrez: '4585'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MARK
  symbol: MARK
  source: hgnc_alias_symbol
  hgnc_symbol: MARK1
  entrez: '4139'
chemicals:
- word: Lapatinib
  source: MESH
  identifier: C490728
- word: Afatinib
  source: MESH
  identifier: C522924
- word: Pelitinib
  source: MESH
  identifier: C413879
diseases: []
figid_alias: PMC8005514__F3
redirect_from: /figures/PMC8005514__F3
figtype: Figure
---
